Cargando…
Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease
Objective. Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton. Early and accurate diagnosis is necessary for the timely and effective treatment of this disease and its common complications. Lipid metabolites form various kinds of bioactive molecules that regulate the...
Autores principales: | Li, Zhengjun, Gu, Wanjian, Wang, Yingzhuo, Qin, Bin, Ji, Wei, Wang, Zhongqiu, Liu, Shijia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855684/ https://www.ncbi.nlm.nih.gov/pubmed/36672555 http://dx.doi.org/10.3390/biomedicines11010047 |
Ejemplares similares
-
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
por: Wen, Chengping, et al.
Publicado: (2017) -
Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021) -
Correction to: Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
por: Wen, Chengping, et al.
Publicado: (2017) -
Non‐genetic biomarkers for ankylosing spondylitis: An umbrella review
por: Lv, Changming, et al.
Publicado: (2022) -
Ankylosing spondylitis
Publicado: (1980)